The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.20
Bid: 143.60
Ask: 144.00
Change: 1.00 (0.70%)
Spread: 0.40 (0.279%)
Open: 145.00
High: 146.00
Low: 143.40
Prev. Close: 143.20
KIE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

16 Nov 2023 16:00

RNS Number : 7395T
Kier Group PLC
16 November 2023

16 November 2023

KIER GROUP PLC

RESULT OF ANNUAL GENERAL MEETING

Kier Group plc (the "Company") announces the results of its Annual General Meeting held on 16 November 2023. The voting was held on a poll and the results for each resolution were as follows:

Resolution

Votes for

% votes for1

Votes against

% votes

Against1

Votes

Withheld2

Total votes validly cast2

% voted3

1

To receive the Annual Report and Accounts for the year ended 30 June 2023

267,582,970

99.99

17,669

0.01

565,221

267,600,639

59.95

2

To approve the Directors' remuneration policy

158,612,472

61.40

99,696,433

38.60

9,860,396

258,308,905

57.87

3

To approve the Directors' remuneration report for the year ended 30 June 2023

267,251,805

99.69

835,349

0.31

82,147

268,087,154

60.06

4

To re-elect Mr MJ Lester as a Director

234,701,884

87.55

33,382,597

12.45

84,820

268,084,481

60.06

5

To re-elect Mr AOB Davies as a Director

261,665,666

97.60

6,439,115

2.40

64,520

268,104,781

60.07

6

To re-elect Mr SJ Kesterton as a Director

267,101,080

99.63

1,003,701

0.37

64,520

268,104,781

60.07

7

To re-elect Mr JR Atkinson as a Director

255,425,116

95.28

12,649,628

4.72

94,557

268,074,744

60.06

8

To re-elect Ms AJ Atkinson as a Director

263,589,918

98.33

4,468,524

1.67

103,996

268,058,442

60.06

9

To re-elect Ms MC Browne OBE as a Director

263,333,064

98.24

4,711,339

1.76

124,898

268,044,403

60.05

10

To elect Ms MG Hassall as a Director

267,823,677

99.92

207,691

0.08

137,933

268,031,368

60.05

11

To re-elect Mr CG Watson as a Director

262,060,542

97.76

6,007,222

2.24

101,537

268,067,764

60.06

12

To re-appoint PricewaterhouseCoopers LLP as auditor

264,311,222

98.62

3,704,415

1.38

138,540

268,015,637

60.05

13

To authorise the Risk Management and Audit Committee to agree the remuneration of the auditor

267,736,509

99.94

166,682

0.06

266,110

267,903,191

60.02

14

To authorise pollical donations

267,073,907

99.70

800,162

0.30

295,232

267,874,069

60.01

15

To authorise the Directors to allot shares

258,042,503

96.31

9,873,616

3.69

238,058

267,916,119

60.02

16

To authorise the Directors to disapply pre-emption rights (general)

266,059,625

99.24

2,034,322

0.76

75,354

268,093,947

60.06

17

To authorise the Directors to disapply pre-emption rights (acquisition or specified capital investment)

265,341,195

98.97

2,768,710

1.03

59,396

268,109,905

60.07

18

To authorise the Company to make market purchases of the Company's ordinary shares of 1p each

267,670,222

99.94

156,871

0.06

342,208

267,827,093

60.00

19

To approve the cancellation of the Company's share premium account

267,866,932

99.93

197,686

0.07

104,683

268,064,618

60.06

20

To approve the cancellation of the Company's capital redemption reserve

267,936,317

99.95

132,553

0.05

100,431

268,068,870

60.06

21

To authorise the Company to call general meetings, other than annual general meetings, on not less than 14 clear days' notice

263,521,613

98.29

4,595,572

1.71

52,116

268,117,185

60.07

Notes:

1. Expressed as a percentage of all votes validly cast (and does not include votes withheld).

2. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes validly cast.

3. Expressed as a percentage of the total issued share capital on 14 November 2023. The number of ordinary shares in issue on 14 November 2023 was 446,354,414.

Shareholders are entitled to one vote per share. Resolutions 1 to 15 (inclusive) were passed as ordinary resolutions and resolutions 16 to 21 (inclusive) were passed as special resolutions.

The Board notes that Resolution 2 (which related to the binding vote on the Directors' Remuneration Policy) was passed with 61.4% of votes in favour. The Chair of the Remuneration Committee consulted extensively with a wide range of shareholders on the proposed Directors' Remuneration Policy which was designed to appropriately incentivise the Chief Executive and Chief Financial Officer to continue to deliver on the medium-term value creation plan, the achievement of which will benefit the Company, its shareholders and other stakeholders. The Board is grateful to shareholders for their engagement earlier in the year and in the lead up to the AGM, during which shareholders expressed different perspectives. The Company remains committed to ongoing shareholder engagement and will continue to do so to ensure that the Company understands shareholders' views and is able to consider feedback on the Company's approach to remuneration going forward. The Company will provide an update on engagement within six months and in next year's annual report, in line with the provisions of the UK Corporate Governance Code.

Following the passing of resolutions 19 and 20, the Company intends to apply to the High Court of Justice in England and Wales (the "Court") to approve the cancellation of both the Company's share premium account and the Company's capital redemption reserve (collectively, the "Capital Reduction"). The expected timetable of principal events with respect to the Capital Reduction is as follows:

Principal event

Date

Expected date for the directions hearing for the Court to consider the Capital Reduction application

1 December 2023

Expected date for the hearing by Court to confirm the Capital Reduction

19 December 2023

Expected date that the Capital Reduction becomes effective

Late December 2023

Notes:

1. The dates set out in this timetable are based on the Company's current expectations and are subject to change. The times and dates are indicative only and will depend, among other things, on the date upon which the Court confirms the Capital Reduction. The provisional final hearing date will be subject to change and dependent on the Court.

2. All times shown are London times unless otherwise stated.

A copy of all resolutions passed, other than those concerning ordinary business, will today be submitted to the National Storage Mechanism in accordance with Listing Rule 9.6.2. These resolutions will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

The Kier Group plc Legal Entity Identifier is 2138002RKCU2OM4Y7O48.

For enquiries, please contact:

Kier Group plc

Jaime Tham

Company Secretary

+44 (0) 7801 975 672

FTI Consulting

Richard Mountain / Ben Fletcher

+44 (0) 20 3727 1340

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGDZMMMKVGGFZM
Date   Source Headline
18th Jan 20189:19 amRNSNotification of change of Director's details
15th Jan 20188:27 amRNSJoint Ventures with Carillion PLC
2nd Jan 201810:29 amRNSBlock listing Interim Review
19th Dec 20172:40 pmRNSDirector/PDMR Shareholding
19th Dec 201711:36 amRNSHolding(s) in Company
15th Dec 20174:01 pmRNSDirector/PDMR Shareholding
15th Dec 201712:20 pmRNSAdditional Listing
14th Dec 20172:05 pmRNSDirector/PDMR Shareholding
6th Dec 20174:41 pmRNSDirector/PDMR Shareholding
5th Dec 201710:47 amRNSDirector/PDMR Shareholding
4th Dec 20175:35 pmRNSDirector/PDMR Shareholding
1st Dec 201711:17 amRNSHolding(s) in Company
30th Nov 20179:28 amRNSHolding(s) in Company
22nd Nov 20174:44 pmRNSDirector/PDMR Shareholding
21st Nov 20173:49 pmRNSDirector/PDMR Shareholding
20th Nov 201711:56 amRNSDirector/PDMR Shareholding
17th Nov 20173:35 pmRNSResult of AGM
17th Nov 20172:44 pmRNSDirector/PDMR Shareholding
17th Nov 201710:01 amRNSDirector/PDMR Shareholding
17th Nov 20177:00 amRNSAGM Trading Update
14th Nov 20177:00 amRNSKier appointed to ESFA £8bn construction framework
13th Nov 20179:50 amRNSHolding(s) in Company
2nd Nov 201710:13 amRNSDirector/PDMR Shareholding
1st Nov 20171:18 pmRNSTotal Voting Rights
25th Oct 20174:53 pmRNSDirector/PDMR Shareholding
25th Oct 20171:21 pmRNSDirector/PDMR Shareholding
24th Oct 20174:04 pmRNSDirector/PDMR Shareholding
23rd Oct 20174:59 pmRNSDirector/PDMR Shareholding
20th Oct 20173:09 pmRNSDirector/PDMR Shareholding
19th Oct 20173:29 pmRNSDirector/PDMR Shareholding
19th Oct 201710:04 amRNSDirector/PDMR Shareholding
16th Oct 201710:47 amRNSAdditional Listing
13th Oct 20172:47 pmRNSDirector/PDMR Shareholding
11th Oct 20175:14 pmRNSAnnual Financial Report
2nd Oct 20173:00 pmRNSDirector/PDMR Shareholding
2nd Oct 201710:28 amRNSTotal Voting Rights
29th Sep 20174:35 pmRNSDirector/PDMR Shareholding
28th Sep 20174:49 pmRNSDirector/PDMR Shareholding
22nd Sep 201710:50 amRNSDirector/PDMR Shareholding
21st Sep 20174:42 pmRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSFinal Results
19th Sep 201710:02 amRNSHolding(s) in Company
11th Sep 20171:59 pmRNSHolding(s) in Company
1st Sep 201712:20 pmRNSTotal Voting Rights
23rd Aug 20173:44 pmRNSHolding(s) in Company
21st Aug 20172:46 pmRNSDirector/PDMR Shareholding
18th Aug 201712:44 pmRNSNotification of change of Director's details
1st Aug 201712:08 pmRNSTotal Voting Rights
1st Aug 20177:00 amRNSDirectorate Change Update
19th Jul 20172:17 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.